Leukemia vaccine being developed

A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed

Leukemia antigen-targeting vaccination therapy is a naturally occurring demand & its establishment is now desired For the treatment of hematological malignancies, including leukemia, striking advances in chemotherapy, targeted therapy such as tyrosine kinase inhibitors, and hematopoietic stem cell transplantation (HSCT), have been made. However, unfortunately, a substantial proportion of patien...

New type of tuberculosis vaccine developed

Health[1] Health[1]Biotechnology [2]Diseases [3]Health [4]Medicine [5]The Body [6]Denmark [7]Videnskab.dk [8] Danish scientists have developed a new vaccine against tuberculosis. The vaccine was created in an entirely new way and may potentially save millions of lives, say the researchers. Tuberculosis annually kills some 1.4 million people, making it one of the world’s deadliest diseases. This...

Leukemia cell-rhabdovirus vaccine: personalized immunotherapy for acute lymphocytic leukemia

Pharmacoeconomic Spotlight on Rotavirus Vaccine RIX4414 (Rotarix™) in Developed Countries

The most common cause of severe diarrhea in infants and young children is rotavirus gastroenteritis (RVGE), which is associated with significant morbidity, healthcare resource use, and direct and indirect costs in industrialized nations. The monovalent rotavirus vaccine RIX4414 (Rotarix™) is administered as a two-dose oral series in infants and has demonstrated protective efficacy against RVGE ...

Group B streptococcal epidemiology and vaccine needs in developed countries.

Development of a group B streptococcal vaccine (GBS) vaccine is the most promising approach for the prevention of GBS infections in babies, given the potential adverse effects of intrapartum antibiotic prophylaxis as well as the need for effective prevention of both adult and late perinatal disease. There are numerous prevention strategies at this time but none are 100% effective in the eradica...